Antiemetic Drugs Market Overview
The Antiemetic Drugs Market size is forecast to reach $4.2 billion by 2025, growing at a CAGR of 6.3% during the forecast period 2020-2025. Antiemetic drugs are those that can treat conditions such as nausea and vomiting. They can be used to treat the aforementioned conditions caused by a range of illnesses. The increasing number of patients suffering from cancer and an increased number of surgeries are the major factors driving the growth of the market. High incidences of gastroenteritis and other diseases that lead to nausea and vomiting is set to further enhance the overall market demand for the Antiemetic Drugs Market during the forecast period 2020-2025.
Report Coverage
The report: “Antiemetic Drugs Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Antiemetic Drugs Market.
By Type of Drugs: 5-HT3 Receptor Antagonists, Dopamine Antagonists, Steroid-Corticosteroids, Benzodiazepines, NK1 Receptor Antagonist, Antihistamines, Cannabinoids, Anticholinergic, and Others
By Applications: Chemotherapy, Pregnancy, Motion Sickness, Food Poisoning, Gastroenteritis, Dizziness, General Anesthetics, Opioid Analgesics, Emotional Stress, and Others
By Geography: North America, Europe, Asia Pacific, and Rest of the World (RoW)
Key Takeaways
North America dominated the Antiemetic Drugs Market in 2019 owing to the increasing incidences of cancer and the higher prevalence of the patient pool undergoing chemotherapy and the availability of the basic hospital infrastructure. The Antiemetic Drugs Market scope for different regions will be provided in the final report.
Increasing usage of drugs to treat the side effects of other medications including opioid analgesics, chemotherapy, and general anesthetics is likely to aid in the market growth of the Antiemetic Drugs Market.
Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Antiemetic Drugs Market report.
Lack of suitable animal model that is set to mimic the human responses to antiemetic therapy and lack of awareness about the variety of antiemetic and antinauseant drugs that are available in the market among the practitioners is set to create hurdles for the Antiemetic Drugs Market.
Type of Drugs - Segment Analysis
The Dopamine Antagonists held the largest share in the Antiemetic Drugs Market in 2019 and is estimated to grow at a CAGR of 5.1% during the forecast period 2020-2025. A dopamine antagonist (anti-dopaminergic) is a type of drug which blocks dopamine receptors by receptor antagonism. Most antipsychotics are dopamine antagonists, and as such, they have found use in treating schizophrenia, bipolar disorder, and stimulant psychosis. The dopaminergic system has been implicated in a variety of disorders. Parkinson's disease results from the loss of dopaminergic neurons in the striatum. Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex of vertebrates, as well as the synthetic analogs of these hormones. Antihistamines are drugs that treat allergic rhinitis and other allergies. Histamine produces increased vascular permeability, causing fluid to escape from capillaries into tissues, which leads to the classic symptoms of an allergic reaction — a runny nose and watery eyes. Histamine also promotes angiogenesis. Benzodiazepines are set to be the highest growing segment and are estimated to register the highest CAGR during the forecast period 2020-2025 owing to its usage to treat anxiety, panic disorders, seizures, muscle tension, and insomnia.
Applications- Segment Analysis
The Chemotherapy segment held the largest share in the Antiemetic Drugs Market in 2019. Chemotherapy is a type of cancer treatment that uses one or more anti-cancer drugs as part of a standardized chemotherapy regimen. Chemotherapy is to be given with a curative intent (which almost always involves combinations of drugs), or it is aim to prolong life or to reduce symptoms (palliative chemotherapy). Traditional chemotherapeutic agents are cytotoxic using interfering with cell division (mitosis) but cancer cells vary widely in their susceptibility to these agents. To a large extent, chemotherapy can be thought of as a way to damage or stress cells, which can then lead to cell death if apoptosis is initiated. Emotional stress involves the experience of negative effects, such as anxiety, in the context of a physiological stress response that includes cardiovascular and hormonal changes. The Opioid Analgesics is set to be the highest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025.
Geography - Segment Analysis
North America dominated the Antiemetic Drugs Market in 2019 with a share of more than 41.8%, followed by the Europe owing to the increasing incidences of cancer and higher prevalence of the patient pool undergoing chemotherapy and the availability of the basic hospital infrastructure. Technological advancements and favorable government support are increasing the growth of the antiemetic drugs market in this region.
However, Europe is estimated to grow at a higher CAGR during the forecast period 2020-2025 owing to the higher adoption of the available treatments. The rapidly increasing population and increase in several diseases are also increasing the growth of the antiemetic drugs market in this region.
Drivers – Antiemetic Drugs Market
Increasing usage of drugs to treat the side effects of other medications including opioid analgesics, chemotherapy and general anesthetics
Increasing usage of drugs to treat the side effects of other medications including opioid analgesics, chemotherapy, and general anesthetics is increasing the growth of the antiemetic drugs market. Chemotherapy is a drug treatment that uses powerful chemicals to kill fast-growing cells in the body. Chemotherapy is most often used to treat cancer since cancer cells grow and multiply much more quickly than most cells in the body. Cancer cells divide much more often than most normal cells, chemotherapy is much more likely to kill them. Some drugs kill dividing cells by damaging the part of the cell's control center that makes it divide. Other drugs interrupt the chemical processes involved in cell division. They treat many different types of cancer, such as leukemia, lymphoma, Hodgkin's disease, multiple myeloma, and sarcoma, as well as breast, lung, and ovarian cancers. Opioids have been regarded for millennia as among the most effective drugs for the treatment of pain. Their use in the management of acute severe pain and chronic pain related to advanced medical illness is considered the standard of care. Thus, increasing the growth of the antiemetic drugs market during the forecast period 2020-2025.
The Increasing number of patients suffering from cancer and increased number of surgeries
The increasing number of patients suffering from cancer and an increased number of surgeries is increasing the growth of the antiemetic drugs market. Cancer is the leading cause of the burden of disease which is measured by mortality and disability and the sixth-most expensive chronic disease, with a cancer diagnosis, treatment, and care. Cancer, also called malignancy, is an abnormal growth of cells. There are more than 100 types of cancer, including breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer, and lymphoma. Symptoms vary depending on the type. Cancer treatment includes chemotherapy, radiation, and/or surgery. The number of patients suffering from cancer and the number of surgeries is increasing owing to the increased lifespan and about two-thirds of the increase is owing to longevity. Changes in alcohol consumption play an important role too. Thus, increasing the growth of the antiemetic drugs market during the forecast period 2020-2025.
Challenges – Antiemetic Drugs Market
Lack of suitable animal model that is set to mimic the human responses to antiemetic therapy and lack of awareness about the variety of antiemetic and antinauseant drugs that are available in the market among the practitioners
Some of the factors that can impede the growth of the Antiemetic Drugs Market are lack of a suitable animal model that is mimic the human responses to antiemetic therapy and lack of awareness about the variety of antiemetic and antinauseant drugs that are available in the market among the practitioners
Antiemetic Drugs Market Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Antiemetic Drugs Market. In 2019, the Antiemetic Drugs Market share is consolidated by the top ten players present in the market. Antiemetic Drugs Market, the top 10 companies are Novartis AG, Sanofi Aventis, Abbott Laboratories, Daiichi Sankyo, Eisai Co., Ltd., GlaxoSmithKline plc, IPCA Laboratories, Merck & Co, F. Hoffmann-La Roche, and Tesaro among others.
Acquisitions/Product Launches
In November 2018, LGM Pharma, an API (active pharmaceutical ingredients) and procurement specialist acquired Zeta for an amount undisclosed which helped LGM Pharma to broaden its portfolio of products offering to better serve the pharmaceutical industry with a broad range of drugs and complimentary services.
For more Lifesciences and Healthcare related reports - Please Click Here
Comments
Post a Comment